Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Peter Gavorník"'
Autor:
Na A Bežillová, Iveta Gasparova, Peter Gavorník, Dáša Mesárošová, Ľudovít Gašpar, Gabriela Gubo, Eva Gavorníková, Martina Kováčová, Andrej Dukát, Alena Uhrinová, Katarína Kusendová, Marek Kucera, Matej Bendžala, Lujza Sabolová, Anna Petrášová
Publikováno v:
Vnitřní lékařství. 65:326-334
Koncatinovocievna arteriova ischemicka choroba (periferne arteriove ochorenie dolných koncatin - PAO DK) je doležitou manifestaciou systemovej aterosklerozy a iných arteriových chorob cievneho systemu. Cim nižsi je clenkovo-ramenový tlakový in
[Antiplatelet thromboprophylaxis of arterial vascular diseases and organovascular ischemic diseases]
Autor:
Anna Petrášová, Eva Gavorníková, Andrej Dukát, Lujza Sabolová, Naďa Hučková, Gabriela Gubo, Ľudovít Gašpar, Iveta Gasparova, Peter Gavorník
Publikováno v:
Vnitrni lekarstvi. 63(2)
Antiplatelet therapy by acetylsalicylic acid (ASA, aspirin) provided pivotal advances in the prevention and treatment of organovascular (angiovascular, cardiovascular, cerebrovascular, extremitovascular, renovascular, genitovascular, mesenteriointest
Autor:
Michal Makovnik, Peter Gavorník, Ivan Ocadlik, Matej Bendzala, Ludovit Gaspar, Andrea Komornikova
Publikováno v:
CBU International Conference Proceedings. 1:307-313
Four major complications are participating in tissue damage in diabetic foot syndrome – diabetic angiopathy, neuropathy, osteoarthropathy and inflammation. Low ankle-brachial pressure index (ABI) is a well-known indicator for ischemia of lower limb
Publikováno v:
Vnitrni lekarstvi. 62(9)
Until recently, vitamin K antagonists (VKA; predominantly warfarin) were the only oral anticoagulants for primary and secondary prevention of venous thromboembolism. Prevention and therapy with novel, direct, non-VKA oral anticoagulant agents (NOACs;
Autor:
Peter, Gavorník
Publikováno v:
Vnitrni lekarstvi. 62(1)
Autor:
Peter, Gavorník, Andrej, Dukát, L'udovít, Gašpar, Nad'a, Hucková, Laura, Slezáková, Katarina, Kusendová, Gabriela, Gubo, Denisa, Medová, Xénia, Faktorová, Eva, Gavorníková
Publikováno v:
Vnitrni lekarstvi. 61(12 Suppl 5)
The aim of this review is to address documents and a number of studies on hypertension published in the last years in order to assess their contribution to our expanding knowledge of arterial hypertension.Arterial hypertension is not defined by sympt
Autor:
Andrej, Dukát, Peter, Sabaka, Ján, Gajdošík, Marjan, Vrbnjak, Oliver, Tlčimuka, Peter, Gavorník, Ľudovít, Gašpar, F, Šimko
Publikováno v:
Vnitrni lekarstvi. 61(12 Suppl 5)
Hyperuricaemia represents nowaday the new risk factor for cardiovascular diseases. Prevalence data and its treatment in our patient´s population are still missing. Literature data shows, that its prevalence differs in various populations significant
Publikováno v:
Vnitrni lekarstvi. 62(1)
The goal of the retrospective observatory cross-sectional study was to evaluate the benefit of alanine aminotransferase screening of blood donors in prevention of hepatitis B and C transmission by haemotherapy in context of actual screening methods.D
Autor:
Peter, Gavorník
Publikováno v:
Casopis lekaru ceskych. 154(6)
Autor:
Peter, Gavorník, Andrej, Dukát, Ľudovít, Gašpar, Denisa, Medová, Xénia, Faktorová, Eva, Gavorníková
Publikováno v:
Vnitrni lekarstvi. 61(7-8)
Erectile dysfunction is a highly prevalent and progressive condition affecting the quality of life of man and his sexual partner. Evidence is accumulating in favour of erectile dysfunction as a sign of a genitovascular disease (GVD) in the majority o